Media Center

CLSI 2019 Q1 CONNECTIONS – Read More


  • Introducing the Spring 2019 FAST Companies Read More
  • CLSI FAST International Concludes Program with Canadian Consulate Read More
  • CLSI Kicks off Partnering Days with JT Pharma Read More
  • CLSI FAST Graduate Abalone Bio Wins California JumpStart Grant from PharmaDirections Read More

FAST Company News

  • Abalone Bio (Fall ’18) was awarded a Phase II SBIR grant from the National Science Foundation
  • Pheronym (Spring ’18) secured a $100K research grant from the International Space Station (ISS) to conduct the first ever agriculture bio-control experiment in space Read More
  • SyntheX (Fall ’16) was announced as recipient of an MBC BioLabs Golden Ticket sponsored by Celgene Corporation Read More
  • Rex Animal Health (Fall ’16) was selected as one of eight startups to be included in fast casual restaurant, Chipotle’s new mentorship program, the Chipotle Aluminaries Project Read More
  • Paragon Genomics (Spring ’16) partners with MGI Tech to distribute its CleanPlex® NGS target enrichment panels worldwide Read More
  • Sandstone Diagnostics (Spring ’13) announced a first pilot study for its new Zero Delay™ Plasma Separation System – a CentriFluidic™ device that provides immediate blood plasma isolation at the point of draw for plasma-based testing Read More
  • Magnetic Insight (Spring ’15) received a SBIR Phase II grant of $1.8 million from the National Institute of Drug Abuse of the NIH to develop a clinical-scale neurovascular magnetic particle imaging system Read More
  • Acorn Product Development and Purigen Biosystems (Spring ’15) announced Breakthrough Platform for extracting, enriching and quantifying DNA and RNA from biological samples Read More


  • CARB-X announced the expansion of its Global Accelerator Network by adding 6 new accelerators Read More
  • CARB-X awards up to $4.4 million to California based company, Recida Therapeutics to support the development of RC-01, a novel LpxC inhibitor with a broad-spectrum anti-gram-negative activity, including against MDR P. aeruginosa isolated from cystic fibrosis patients Read More
  • Forge Therapeutics is granted a second award of up to $11.1M from CARB-X to support development of their LpxC inhibitor to treat serious lung infections Read More
  • Achaogen announced FDA clearance and launch for the Thermo Scientific QMS Plazomicin Immunoassay Read More


CLSI/CLSA events

  • 3/26 CLSA Innovation Breakfast: Data Management Strategies, San Diego
  • 3/28 Bio on the Bay with CLSA, San Francisco
  • 4/8 CLSA & NIIMBL: A Partnership To Accelerate Innovation In Biopharmaceutical Manufacturing
  • 4/9 FAST and Fellows Networking Happy Hour, South San Francisco (Invitation Only)
  • 4/18 Bio in the Brewery with CLSA, San Diego
  • 6/11 FAST Spring International Closing Showcase (Invitation Only)

Community Events

  • 3/14 QB3 Seminar: Sushmita Venkatraman, Linus Group “Persuading Scientists: A Strategic Marketing Model”, San Francisco
  • 3/19 JLABS: Meet with Bioverge, South San Francisco
  • 3/21 QB3 Seminar: Gina Poon, Covered California “Healthcare Plans for Small Business”, San Francisco
  • 3/22 IndieBio Post-Future Food Tech Reception, San Francisco
  • 3/26 Rosenman D-Series: Kevin Chu, F-Prime Capital. “How a VC Sees the Current Medtech Landscape”, San Francisco
  • 3/27 JLABS: Protecting and Profiting from your Intellectual Property, South San Francisco
  • 3/28 GARDP Clinical development for non-developers Part 3: Antibacterial Drug Enhancer Combinations and Non-traditional Products Webinar
  • 3/28 Advances in Biologics Development & Delivery: Catalent Symposium, San Francisco
  • 4/1 SkyDeck Fall 2019 applications open
  • 4/2 JLABS: What does Pharma want and need from Digital?, South San Francisco
  • 4/2 Life Sciences Pioneers Dinner: San Francisco Bay Area
  • 4/10 UCSF Startup 101: Pitch Night, San Francisco
  • 4/11 QB3 Seminar: Kris Corzine “Customer Discovery and Go-to-Market Strategy”, San Francisco
  • 4/18 Deadline to Apply to join 2019 Rosenman Innovators
  • 4/23 Rosenman D-Series: Nada Hanafi, Experien Group. “Critical Success Factors for Regulatory Strategy”, San Francisco
  • 4/24-26 The Society for Healthcare Epidemiology of America (SHEA) Spring 2019 Conference, Boston
  • 6/3-6 2019 BIO International Convention, Philadelphia
  • 6/20-24 ASM Microbe 2019, San Francisco
  • 9/3-6 ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance, Boston
  • 10/2-6 IDWeek 2019, Washington DC